James Andrew Pierce
Known title: DirectorCIK: 0001886518
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Stryker's $400M Robotics Deal and FDA Clearance of Sonopet 3. Stryker announced a $400 million agreement to expand its robotics portfolio, detailing the technologies and capabilities it will acquire. In a separate update, the company received FDA clearance for the Sonopet 3, a new tool within its surgical platform. Both moves broaden Stryker’s product range and may support future revenue growth. The developments come as the stock trades near its recent support level.
Transaction History
| NVST | ▲ Buy | Grant | 9,330 | $0 | 5/19/2026 | View on chart |
| SYK | ▲ Buy | Option Exercise | 430 | $0 | 3/21/2026 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 7,807 | $2.6M | 3/21/2026 | View on chart |
| SYK | ▲ Buy | Grant | 14,912 | $0 | 3/9/2026 | View on chart |
| SYK | ▲ Buy | Grant | 2,771 | $0 | 2/4/2026 | View on chart |
| SYK | ▲ Buy | Option Exercise | 13,840 | $1.3M | 2/2/2026 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 8,432 | $3.1M | 2/2/2026 | View on chart |
| SYK | ▼ Sell | Open Market | 475 | $175K | 2/2/2026 | View on chart |
| SYK | ▼ Sell | Gift | 106 | $0 | 11/21/2025 | View on chart |
| SYK | ▼ Sell | Gift | 105 | $0 | 11/21/2025 | View on chart |
| SYK | ▼ Sell | Gift | 211 | $0 | 11/21/2025 | View on chart |
| NVST | ▲ Buy | Grant | 9,155 | $0 | 7/14/2025 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 6,720 | $2.5M | 3/21/2025 | View on chart |
| SYK | ▲ Buy | Option Exercise | 314 | $0 | 3/21/2025 | View on chart |
| SYK | ▲ Buy | Grant | 12,916 | $0 | 3/10/2025 | View on chart |
| SYK | ▲ Buy | Option Exercise | 9,455 | $880K | 1/29/2025 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 5,537 | $2.2M | 1/29/2025 | View on chart |
| SYK | ▼ Sell | Gift | 99 | $0 | 12/23/2024 | View on chart |
| SYK | ▼ Sell | Gift | 99 | $0 | 12/23/2024 | View on chart |
| SYK | ▼ Sell | Gift | 198 | $0 | 12/23/2024 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 641 | $232K | 10/1/2024 | View on chart |
| SYK | ▲ Buy | Option Exercise | 203 | $0 | 3/21/2024 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 4,412 | $1.6M | 3/21/2024 | View on chart |
| SYK | ▲ Buy | Grant | 8,499 | $0 | 3/11/2024 | View on chart |
| SYK | ▲ Buy | Option Exercise | 10,230 | $830K | 1/16/2024 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 6,037 | $1.9M | 1/16/2024 | View on chart |
| SYK | ▼ Sell | Gift | 262 | $0 | 12/20/2023 | View on chart |
| SYK | ▼ Sell | Gift | 131 | $0 | 12/20/2023 | View on chart |
| SYK | ▼ Sell | Gift | 131 | $0 | 12/20/2023 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 627 | $171K | 10/1/2023 | View on chart |
| SYK | ▲ Buy | Option Exercise | 107 | $0 | 3/21/2023 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 1,952 | $540K | 3/21/2023 | View on chart |
| SYK | ▲ Buy | Grant | 3,827 | $0 | 3/7/2023 | View on chart |
| SYK | ▲ Buy | Option Exercise | 12,500 | $800K | 2/2/2023 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 7,128 | $2.0M | 2/2/2023 | View on chart |
| SYK | ▼ Sell | Open Market | 400 | $111K | 2/2/2023 | View on chart |
| SYK | ▼ Sell | Gift | 262 | $0 | 12/28/2022 | View on chart |
| SYK | ▼ Sell | Gift | 131 | $0 | 12/28/2022 | View on chart |
| SYK | ▼ Sell | Gift | 131 | $0 | 12/28/2022 | View on chart |
| SYK | ▲ Buy | Option Exercise | 1,264 | $0 | 10/1/2022 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 627 | $127K | 10/1/2022 | View on chart |
| SYK | ▲ Buy | Option Exercise | 765 | $0 | 8/1/2022 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 380 | $82K | 8/1/2022 | View on chart |
| SYK | ▲ Buy | Option Exercise | 5,168 | $0 | 3/21/2022 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 2,351 | $629K | 3/21/2022 | View on chart |
| SYK | ▲ Buy | Option Exercise | 1,765 | $95K | 12/3/2021 | View on chart |
| SYK | ▼ Sell | Tax Withholding | 1,069 | $264K | 12/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Piper Sandler cuts Envista price target to $26, maintains Neutral
Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.
Piper Sandler cuts Envista price target to $26, maintains Neutral. Piper Sandler recently lowered its price target for Envista Holdings to $26 while keeping a Neutral stance. This move aligns with the stock's current trading level near its 52-week low of $18.77. The company has also scheduled its third-quarter 2026 earnings call, which will provide updated financial insights.